ELI LILLY & Co (LLY)

↓ Download CSV

CIK 0000059478 · NYSE · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated IN
  • Fiscal year ends Dec 31

In fiscal 2025, ELI LILLY & Co reported revenue of $65.18B, up 44.7% from the prior year. The company was profitable, with a net margin of 31.7%.

Key ratios (FY2025)

31.7%
Net margin
77.8%
Return on equity
+44.7%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$65.18B$45.04B$34.12B$28.54B$28.32B$24.54B$22.32B$21.49B$19.97B$18.31B
Cost of Revenue$11.05B$8.42B$7.08B$6.63B$7.31B$5.48B$4.72B$4.68B$4.45B$4.16B
Net Income$20.64B$10.59B$5.24B$6.24B$5.58B$6.19B$8.32B$3.23B-$204.10M$2.74B
EPS (Diluted)$22.95$11.71$5.80$6.90$6.12$6.79$8.89$3.13$-0.19$2.58
Total Assets$112.48B$78.72B$64.01B$49.49B$48.81B$46.63B$39.29B$43.91B$44.98B$38.81B
Shareholders' Equity$26.54B$14.27B$10.77B$10.65B$8.98B$5.64B$2.61B$9.83B$11.59B$14.01B
Cash & Equivalents$7.27B$3.27B$2.82B$2.07B$3.82B$3.66B$2.34B$7.32B$6.21B$4.58B
Operating Cash Flow$16.81B$8.82B$4.24B$7.59B$7.37B$6.50B$4.84B$5.52B$5.62B$4.85B
Shares Outstanding899.30M904.10M903.30M904.62M911.68M912.50M935.68M1.03B1.05B1.06B
Dividends Per Share$6.23$5.40$4.69$4.07$3.53$3.07$2.68$2.33$2.12$2.05